ZFIN Image: Ding et al., 2022, Fig. 1

Image

Figure Caption

Fig. 1

Genetic testing identified GBT411/dnajb6 as a deleterious modifier for bag3 cardiomyopathy. (A,B) Levels of ejection fraction (EF) and fractional shortening (FS) (in %) of bag3^e2/e2;sorbs2b^−/−, bag3^e2/e2;ano5a^−/− and bag3^e2/e2;rxraa^−/− double-mutant fish compared to bag3^e2/e2 single-mutant and WT control fish at 6 months; n=6-15, one-way ANOVA. (C) Survival (in %) of bag3^e2/e2;GB411^−/− double-mutant fish compared to single-mutant and WT control fish; n=15-24, log-rank test. (D) FS of bag3^e2/e2;dnajb6b^−/− double-mutant fish compared to single-mutant and WT control fish at 6 days dpf; n=6-7, one-way ANOVA. (E,F) Images of ventricular chamber outlines (E) and quantification of its size (F) of bag3^e2/e2;GB411^−/− double-mutant hearts at systolic stage compared to single mutants and WT controls, n=6. One-way ANOVA. Scale bar: 100 µm. *P<0.05. ns, not significant.

Figure Data

Phenotype details

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dis. Model. Mech.